ज वऔषध करण क क र त और प रत क र य

The review assesses and provides recommendations for policy measures to develop the biopharmaceutical industry as a sector for reducing the country's dependence on the oil sector.

At the global level, this industry is represented by the International Federation of Pharmaceutical Manufacturers and Associations (IFPMA).

Individual corporations in the pharmaceutical industry generally do have comprehensive codes of conduct, covering a wide range of ethical aspects of research and commerce, but none has a specific reference to biological weapons.

These activities include joint research projects of selected generic drugs and biopharmaceuticals, as well as the creation of a young professional programme, designed to provide conceptual and practical training in the biopharmaceutical industry, for practitioners from developing countries.

New investment was made in the electronic, chemical, and pharmaceutical sectors, which were industry leaders in eastern Europe in the mid 1980s.

While many international, regional and national biotechnology federations and associations have codes of conduct which include specific mention of biological weapons, this appears not to be the case for the pharmaceutical research and manufacturing sector.

It is followed by the manufacturing sector, which consists of petroleum refining, textiles, electronics, pharmaceuticals and watch and jewellery assembly.22

A larger proportion of Governments (48 per cent) had enhanced cooperation with the chemical industry to prevent the diversion of precursors of ATS and with the pharmaceutical industry (42 per cent) to prevent the diversion of licit pharmaceuticals containing ATS.

Almost half of the reporting Governments (48 per cent) had enhanced cooperation with the chemical industry to prevent the diversion of precursors of amphetamine type stimulants and with the pharmaceutical industry (42 per cent) to prevent the diversion of licit pharmaceuticals containing amphetamine type stimulants.

Recalling its resolution 45 6, in which it encouraged States to involve the pharmaceutical industry in increasing knowledge about the potential for abuse of and dependence on psychoactive substances,

Recalling its resolution 45 6, in which it encouraged States to involve the pharmaceutical industry in increasing knowledge about the potential for abuse of and dependence on psychoactive substances,

Given that childhood cancers are all rare or ultra rare diseases, the ability of the biopharmaceutical industry to invest resources into development of new treatments is limited at best.

Pharmaceutical Myths

UNEP, through its biosafety activities, has also been working with industry representatives through the Global Industry Coalition and non governmental organizations interested in biosafety through the Third World Network.

There are three areas of typical codes of conduct of pharmaceutical corporations that might be of relevance, or serve as models, when considering how biological weapons issues might be included in codes of conduct.

Applications It is used to manufacture pharmaceuticals and organic chemicals.

The public system for procurement, distribution and management of pharmaceutical products is weak.

Development costs of 800 million are not unusual for a drug, and we can expect to see more of a new type of drug biopharmaceuticals made from living cells which cost even more.

Industry

Biological Weapons

The pharmaceutical, biotechnology and other relevant industries

Industry

(i) Biological weapons

Biological Weapons Convention

What s an Industry?

(v) Promoting access to low cost and effective drugs and related pharmaceutical products

In African medicine, Chinese herbs and pharmaceuticals are quietly gaining share.

But the Indian decision also means less money for the big multinational pharmaceutical companies.

Pharmaceuticals, educational and nutritional supplies showed clear signs of growth.

Biological and nuclear weapons Albania acceded to the Biological Weapons Convention on June 3, 1992, banning biological weapons.

Regulators need to hire industry experts to regulate effectively but industry experts are almost bound to share the industry s implicit assumptions.

Legislation with respect to biological weapons

Biological Weapons Programme of Iraq (extracted from the compendium summary)

Development of the biological weapons programme

The biosafety outstation conducts research on the biosafety of genetically modified organisms.

He is considered to be the source for all Greek pharmacotherapeutic treatises between the time of Theophrastus and Dioscorides.

Ministry of Industry, Commerce and Tourism

(a) Livelihood industry development

The potential is there, but too often government talks to government and industry talks to industry.

In particular, section 8 of the Crimes (Biological Weapons) Act places a restriction on the development, production, stockpiling, acquisition or retention of certain biological agents and toxins and biological weapons.

Biological Weapons and Related Material

It reports on activities under the Biotrade Initiative.

There is solid evidence that the benefits of intra industry trade vary depending upon the nature of the industry and the intensity of the fragmentation.

The biosafety unit provides institutional services related to the biosafety of genetically modified organisms and their release to the environment.